Shattuck Labs (STTK) Net Income towards Common Stockholders (2019 - 2026)

Shattuck Labs' (STTK) quarterly Net Income towards Common Stockholders came in at -$14.8 million in Q1 2026, down 7.78% year-on-year from -$16.0 million in Q1 2025, and up 87.7% on a QoQ basis from -$120.1 million in Q4 2025.

Shattuck Labs (STTK) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends

Shattuck Labs (STTK) has 8 years of Net Income towards Common Stockholders data on file, last reported at -$14.8 million in Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 7.78% year-over-year to -$14.8 million in Q1 2026; TTM through Mar 2026 was -$159.1 million, a 7.49% increase from a year earlier, with the FY2025 full-year figure at -$155.5 million, up 9.08% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$14.8 million, up from -$120.1 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for STTK reached as high as -$11.1 million in Q3 2025 and fell as low as -$120.1 million in Q4 2025.
  • Historically, Net Income towards Common Stockholders has averaged -$38.3 million across 5 years, with a median of -$26.1 million in 2022.
  • Across the five-year window, Net Income towards Common Stockholders tumbled 265.61% in 2023 and soared 57.77% in 2025, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at -$26.1 million in 2022, then tumbled by 265.61% to -$95.3 million in 2023, then fell by 20.9% to -$115.3 million in 2024, then retreated by 4.16% to -$120.1 million in 2025, then surged by 87.7% to -$14.8 million in 2026.
  • Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$14.8 million in Q1 2026, -$120.1 million in Q4 2025, and -$11.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Oculis Holding AG 68,184.45 Bn 68,184.17 Bn - -625.73
2 Nanobiotix 1,953.19 Bn 1,953.13 Bn - -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn - -14.46 Mn
4 BeOne Medicines 474.39 Bn 469.59 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 123.45 Bn 116.21 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 69.92 Bn 61.16 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 63.43 Bn 63.43 Bn - -0.68
8 Argenx Se 56.67 Bn 51.49 Bn 1.41 Bn 472.00 Mn
9 Revolution Medicines 38.08 Bn 38.08 Bn - -453.82 Mn
10 Shattuck Labs 848.49 Mn 848.49 Mn - -14.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.77 Mn
Dec 31, 2025 -120.06 Mn
Sep 30, 2025 -11.12 Mn
Jun 30, 2025 -13.13 Mn
Mar 31, 2025 -13.70 Mn
Dec 31, 2024 -115.26 Mn
Sep 30, 2024 -18.72 Mn
Jun 30, 2024 -24.26 Mn
Mar 31, 2024 -32.44 Mn
Dec 31, 2023 -95.34 Mn
Sep 30, 2023 -28.70 Mn
Jun 30, 2023 -23.05 Mn
Mar 31, 2023 -21.86 Mn
Dec 31, 2022 -26.08 Mn
Sep 30, 2022 -31.67 Mn
Jun 30, 2022 -29.15 Mn
Mar 31, 2022 -31.11 Mn
Dec 31, 2021 -22.41 Mn
Sep 30, 2021 -36.63 Mn
Jun 30, 2021 -49.51 Mn